2019
DOI: 10.1016/j.tibtech.2018.08.005
|View full text |Cite
|
Sign up to set email alerts
|

Deep Learning with Microfluidics for Biotechnology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
129
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 178 publications
(129 citation statements)
references
References 93 publications
0
129
0
Order By: Relevance
“…DL depends on algorithms for reasoning process simulation and data mining, or for developing abstractions [17]. Hidden deep layers on DL maps input data to labels to analyze hidden patterns in complicated data [18]. Besides their use in medical X-ray recognition, DL architectures are also used in other areas in the application of image processing and computer vision in medical.…”
Section: Introductionmentioning
confidence: 99%
“…DL depends on algorithms for reasoning process simulation and data mining, or for developing abstractions [17]. Hidden deep layers on DL maps input data to labels to analyze hidden patterns in complicated data [18]. Besides their use in medical X-ray recognition, DL architectures are also used in other areas in the application of image processing and computer vision in medical.…”
Section: Introductionmentioning
confidence: 99%
“…We envision that microfluidics will continue to be integrated into different research topics and applications, with new innovation through combination with emerging disciplines, such as artificial intelligence,7,8 metamaterials9 and neuromorphic engineering 10. As the field has matured, microfluidics has played a key role in numerous applications and products that will reshape segmented markets.…”
mentioning
confidence: 99%
“…Multiple screening and selection technologies are also available for isolating high‐performance mutants from genetically diverse populations. Emerging microfluidic technologies will also drive a transition to automation, parallelization, and miniaturization of many screening assays . An often overlooked aspect of the whole process is the scaling‐up of fermentations using engineered MCFs, including critical performance indicators such as catalytic durability, genetic stability, and evolvability .…”
Section: Conclusion and The Way Aheadmentioning
confidence: 99%
“…Emerging microfluidic technologies will also drive a transition to automation, parallelization, and miniaturization of many screening assays. [99] An often overlooked aspect of the whole process is the scaling-up of fermentations using engineered MCFs, including critical performance indicators such as catalytic durability, genetic stability, and evolvability. [100] Although most of the (narrow) literature available on these matters deals with planktonic bacteria growing in liquid cultures, the same questions are likewise relevant for alternative cultivation setups, such as catalytic biofilms.…”
Section: Conclusion and The Way Aheadmentioning
confidence: 99%